Literature DB >> 25898976

Clinical characterization of a male patient with the recently described 8q21.11 microdeletion syndrome.

Ines Quintela1, Francisco Barros2, Manuel Castro-Gago3, Angel Carracedo1,2,4, Jesus Eiris3.   

Abstract

The 8q21.11 microdeletion syndrome (OMIM # 614230) has been recently described and is primarily characterized by intellectual disability and facial dysmorphism. We describe here a male patient of 9 years 9 months of age with moderate intellectual disability and dysmorphic facial features. A high resolution copy number variation analysis, performed with the Affymetrix Cytogenetics Whole-Genome 2.7 M SNP array, allowed the identification of a heterozygous 7.069 Mb microdeletion at chromosome 8q21.11-q21.13. Clinical comparison of our patient with literature shows many similarities. However, the whole facial appearance of our patient, especially the elongated rather than rounded face and the absence of a wide nasal bridge and epicanthal folds, confers him a phenotype similar only to a subset, but not to the majority, of the hitherto described patients.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  8q21.11 microdeletion syndrome; 8q21.11-q21.13 microdeletion; SNP array; dysmorphism; intellectual disability

Mesh:

Year:  2015        PMID: 25898976     DOI: 10.1002/ajmg.a.37038

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  8q21.11 microdeletion syndrome: Delineation of HEY1 as a candidate gene in neurodevelopmental and cardiac defects.

Authors:  Ikhlas Ben Ayed; Amal Bouzid; Fatma Kammoun; Amal Souissi; Olfa Jallouli; Salma Mallouli; Souhir Guidara; Salma Loukil; Hajer Aloulou; Fida Jbeli; Sahar Aouichaoui; Dorra Abid; Fatma Abdelhedi; Chahnez Triki; Hassen Kamoun; Saber Masmoudi
Journal:  Mol Genet Genomic Med       Date:  2021-09-22       Impact factor: 2.183

2.  Chromosomal Microarray Analysis for the Fetuses with Aortic Arch Abnormalities and Normal Karyotype.

Authors:  Xiaoqing Wu; Ying Li; Linjuan Su; Xiaorui Xie; Meiying Cai; Na Lin; Hailong Huang; Yuan Lin; Liangpu Xu
Journal:  Mol Diagn Ther       Date:  2020-10       Impact factor: 4.074

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.